Mar 16th, 2023 - Janssen COVID-19 vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older for whom other FDA-authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and in individuals...

Feb 23rd, 2023 - SPL UNCLASSIFIED SECTION FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR LAGEVRIO™ (molnupiravir) CAPSULES HIGHLIGHTS OF EMERGENCY USE AUTHORIZATION (EUA) These highlights of the EUA do not include all the information needed to use LAGEVRIO under the EUA. See the FULL FACT SHEET FOR HEALTHCARE PROVIDERS for LAGEVRIO. LAGEVRIO™ (molnupiravir) capsules, for oral use Original ...

Jan 26th, 2023 - Dilute with 5g of oil in 500ml of waterAntibacterial, anti-fungal, indoor air purification, humidity control and insect repellent, sick house syndrome, formaldehyde neutralization, forest bathing effect and stress relief, sterilization deodorization, hand sanitizer, super bacteria inhibition, sleep effect, house mite avoidance, allergy and atopy improvement

Dec 29th, 2022 - Pfizer-BioNTech COVID-19 Vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older. This EUA Prescribing Information pertains only to Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial...

Dec 21st, 2022 - SPL UNCLASSIFIED SECTION HIGHLIGHTS OF EMERGENCY USE AUTHORIZATION (EUA) These highlights of the EUA do not include all the information needed to use EVUSHELD™ under the EUA. See the FULL FACT SHEET FOR HEALTHCARE PROVIDERS for EVUSHELD. EVUSHELD (tixagevimab) injection; (cilgavimab) injection, co-packaged for intramuscular use Original EUA Authorized Date: 12/2021 Revised EUA Authorized Date: ...

Dec 12th, 2022 - Pfizer-BioNTech COVID-19 Vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older. This EUA Prescribing Information pertains only to Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial...

Dec 9th, 2022 - SPL UNCLASSIFIED SECTION MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) BOOSTER DOSE FOR 6 MONTHS THROUGH 5 YEARS OF AGE AT LEAST 2 MONTHS AFTER COMPLETION OF PRIMARY VACCINATION WITH MODERNA COVID-19 VACCINE   The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Moderna COVID-19 ...

Nov 29th, 2022 - Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 5 years of age and older. This EUA Prescribing Information pertains only to Pfizer-BioNTech COVID-1...

Sep 19th, 2022 - Covid-19 treatment supplements without side effectsrelieves symptoms from Covid-19 or various infection. Pain reliever / fever reducer / Nasal decongestant

Sep 9th, 2022 - SPL UNCLASSIFIED SECTION PRIMARY SERIES For 12 Years and Older   The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, MODERNA COVID-19 VACCINE, for active immunization to prevent COVID-19 in individuals 6 months of age and older. This Fact Sheet pertains only to Moderna COVID-19 Vaccine supplied in a ...

Sep 9th, 2022 - Covid-19 treatment supplements without side effectsrelieves symptoms from Covid-19 or various infection. Pain reliever / fever reducer / Nasal decongestant

Sep 7th, 2022 - SPL UNCLASSIFIED SECTION PRIMARY SERIES 6 years through 11 years of age The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Moderna COVID-19 Vaccine, for active immunization to prevent COVID-19 in individuals 6 months of age and older. There are 2 presentations of Moderna COVID-19 Vaccine authorized f...

Sep 2nd, 2022 - Pfizer-BioNTech COVID-19 Vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older. This EUA Prescribing Information pertains only to Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial...

Sep 2nd, 2022 - Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. This EUA Prescribing Information pertains only to Pfizer-BioNTech COVID-...

Aug 15th, 2022 - PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Pfizer-BioNTech COVID-19 Vaccine, Bivalent Original and Omicron BA.4/BA.5 DILUTE PRIOR TO USE Age 5y to < 12y After dilution - 10 doses of 0.2 mL For intramuscular use. Contains no preservative. For use under Emergency Use Authorization. After dilution store at 2 to 25°C (35 to 77°F) and discard after 12 hours. Dilution date and time: NDC 59267-0565-1 PRINC...

Aug 5th, 2022 - SPL UNCLASSIFIED SECTION HIGHLIGHTS OF EMERGENCY USE AUTHORIZATION (EUA) These highlights of the EUA do not include all the information needed to use BEBTELOVIMAB under the EUA. See the FULL FACT SHEET FOR HEALTHCARE PROVIDERS for BEBTELOVIMAB. BEBTELOVIMAB injection for intravenous use Original EUA Authorized Date: 02/2022 Revised EUA Authorized Date: 08/2022 ----------------------------RECENT...

Jul 28th, 2022 - SPL UNCLASSIFIED SECTION MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) BOOSTER DOSE FOR 18 YEARS OF AGE AND OLDER The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5), for active immunization to prevent COVID-19 i...

Jul 26th, 2022 - SPL UNCLASSIFIED SECTION The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Novavax COVID-19 Vaccine, Adjuvanted, for active immunization to prevent COVID-19 in individuals 18 years of age and older. SPL UNCLASSIFIED SECTION Vaccination providers enrolled in the federal COVID-19 Vaccination Program...

Jul 12th, 2022 - COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in in...

Jul 1st, 2022 - The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of the unapproved product PAXLOVID for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct severe acute respiratory syndrome coronavirus 2 (SARS-CoV...